The study included data from people with a recent history of obesity and excluded those with diabetes or who have been prescribed another Scientists analyzed the data to see how many people developed one of four gastrointestinal conditions pancreatitis, bowel obstruction, gastroparesis, and Researchers found that the participants who took GLP-1 agonists had a little over nine times higher risk of developing pancreatitis, 4.22 times higher risk of having a bowel obstruction, and 3.67 times increased risk for gastroparesis, compared to people who took We are not entirely surprised [by these results]
How common is nausea on semaglutide versus tirzepatide
doi: 10.1111/obr.12603
Over the past few years, we have been able to increase access to healthcare across Georgia and into our rural communities by partnering with local leaders, businesses and organizations to identify and meet the rapidly expanding needs of our patients and their families. If approved, the proposed Acworth hospital would provide several benefits for the health and well-being of the region: Easier access to emergency care
Although the study primarily reports clinical outcomes, changes in specific biomarkers indirectly suggest potential mechanisms of action of GLP-1RAs
This common question arises among patients using Ozempic, Wegovy, or Rybelsus for diabetes or weight management